First-in-Class Experimental CAR T-Cell Therapy Shows Promise Against Solid Tumors, Study Finds A first-in-class experimental CAR T-cell therapy has demonstrated preliminary success in targeting solid tumors, according to a 2023 …
Antigen
-
-
Engineered CAR T Cells Show Promise in Targeting Bladder Cancer in Mouse Studies Engineered CAR T cell therapy has demonstrated efficacy in targeting bladder cancer in preclinical mouse models, according …
-
Understanding the Impact of Nano-Silica on Allergic Responses As allergic respiratory diseases continue to rise globally, researchers are increasingly investigating how environmental factors—specifically components of air pollution—interact with our immune …
-
Kenyan bat coronavirus uses human CEACAM6 to enter cells, raising spillover concerns An international team of researchers has identified an East African bat coronavirus capable of entering human cells through …
-
How the Immune System Influences Alzheimer’s and Parkinson’s Disease The brain’s immune system plays a dual role in neurodegenerative diseases like Alzheimer’s and Parkinson’s, acting as both a protector and …
-
Health
γδ T Cell Heterogeneity: Single-Cell Analysis Reveals Preexisting Activation States & Implications for Immunotherapy
Pre-existing Activation States Shape Functional Heterogeneity of Human Vγ9Vδ2 T Cells γδ T cells are gaining prominence in cancer immunotherapy due to their ability to target tumors. However, their diverse …
-
CD4+ T Cells: Reframing Cancer Immunotherapy For decades, cancer immunotherapy has largely focused on CD8+ cytotoxic T lymphocytes as the primary drivers of tumor cell destruction. However, emerging clinical evidence …
-
New Platform Enhances CAR T-Cell Therapy for Relapsed Leukemia Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of leukemia, but relapse remains a significant challenge. Now, a novel …
-
Genetic Mismatch Linked to Severe Complications in Cord Blood Transplants A recent Japanese study of over 7,400 patients has identified a specific genetic mismatch that significantly increases the risk of …
-
Switchable CAR-T Cells Offer New Hope for Cancer Treatment Engineered immune cells, known as chimeric antigen-receptor (CAR) T cells, have revolutionized the treatment of blood cancers, but limitations remain. Researchers …